MoonLake Immunotherapeutics Income Statement

Income Statement Dec2022 Dec2023 Dec2024
Operating items
Research & Development 42.05M31.80M112.77M
Selling, General & Administrative 23.01M22.32M30.32M
Operating Expenses 65.06M54.12M143.09M
Operating Income -65.06M-54.12M-143.09M
EBIT -65.06M-54.12M-143.09M
Non-operating items
Other Non Operating Income 0.59M10.14M22.13M
Non Operating Income 0.59M
Net income details
EBT -64.47M-43.98M-120.96M
Tax Provisions 0.04M0.09M0.28M
Profit After Tax -64.51M-44.08M-121.24M
Income from Non-Controlling Interests -14.53M-8.07M-2.31M
Income from Continuing Operations -64.51M-44.08M-121.24M
Consolidated Net Income -64.51M-44.08M-121.24M
Income towards Parent Company -64.51M-44.08M-121.24M
Net Income towards Common Stockholders -64.51M-44.08M-121.24M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 52.70M63.89M63.91M
EBITDA -63.85M-42.09M-118.65M